Skip to content

Efficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia.

Efficacy and Safety of Intermittent Bolus Comparing With Traditional Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia at Rajavithi Hospital

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04561531
Enrollment
40
Registered
2020-09-23
Start date
2020-09-30
Completion date
2021-09-30
Last updated
2021-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyponatremia, Osmotic Demyelination Syndrome

Brief summary

To compare between intermittent bolus and traditional continuous drip of 3%NaCl in patients with severe symptomatic hyponatremia in Rajavithi Hospital.

Detailed description

Background: Hyponatremia is the most common electrolyte imbalance in clinical practice, associated with increased mortality and length of stay. In 2014,European guideline have recommended promp infusion of 3%NaCl 150 ml in 20 minutes to raise plasma Na to 5 mmol/L and improve symptoms. The recommendation was the result of studies with small numbers of patients, and expert opinions. Methods: A single center opened-label randomized controlled-trial,we will randomly assign 40 patients with severe symptomatic hyponatremia (plasmaNa\<125mmol/L) in Rajavithi Hospital into two groups: First group receive intermittent bolus of 3%NaCl 150 ml in 30 minutes and follow plasma sodium until achieve target of goal plasma sodium = 5 mmol/L in 6 hours (no more than 12 mmol/L in 24 hr and 18 mmol/L in 48 hr),another receive traditional continuous drip of 3%NaCl start with rate = 1ml/kg/hr and follow plasma sodium every 1 hour until achieve target of plasma sodium 5 mmol/L in 6 hours .The primary end point is change in plasma sodium in 6 hours and improvement of glasglow coma scale.The secondary end points are change in plasma sodium in 24,48 hours,overcorrection rate in 24 and 48 hours ,ODS rate ,hospitality days and mortality rate.

Interventions

OTHER3%NaCl

Intervention is infusion of 3%NaCl which is defined in arms of experiment.

Sponsors

Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients in Rajavithi Hospital * Age from 18 years * Plasma Na \< 125 mmol/l with glucose-corrected * Severe symptomatic hyponatremia (Vomitting ,Coma ,Somnolence)

Exclusion criteria

* Systolic BP \< 90 mmHg Or MAP\< 70 mmHg * Pregnancy or Lactation * Congestive Heart Failure or Volume overload * Lung congestionfrom CXR * Chronic renal failure patients with edema * Cirrhosis patients with edema * Patients with coronary artery disease * Patients with brain injuries * Deny consent

Design outcomes

Primary

MeasureTime frameDescription
Plasma sodium and glasglow coma scale(GCS)6 hoursChange in plasma sodium and level of consciousness (GCS)

Secondary

MeasureTime frameDescription
Plasma sodium and glasglow coma scale(GCS)24 and 48 hoursChange in plasma sodium and level of consciousness (GCS)
overcorrection rate24 and 48 hoursrate of overcorrection which defined as change in plasma sodium over 12 mmol/L in 24 hr and 18 mmol/L in 48 hr
ODS ratein 7 daysrate of osmotic demyelinating syndrome
hospitality daysuntil dischargehospitality days
mortality ratein 30 daysmortality rate

Countries

Thailand

Contacts

Primary ContactOrakan Lanwong
orakanpor@gmail.com0803625252
Backup ContactKumtorn Lelamali
lelamali01@yahoo.com0967816239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026